Feb 03, 2020 8:30am EST Artelo Biosciences Announces NCI Grant of $4.2 Million to Stony Brook University to Advance FABP5 Inhibitor Cancer Program
Jan 14, 2020 8:00am EST Artelo Biosciences Reports First Quarter Fiscal Year 2020 Financial Results and Provides Business Update
Dec 09, 2019 8:30am EST Artelo Biosciences Announces Appointment of Seasoned Finance and Industry Executive John W. Beck to Board of Directors
Nov 25, 2019 8:00am EST Artelo Biosciences Reports Fourth Quarter and Fiscal Year 2019 Financial Results and Provides Business Update
Nov 18, 2019 8:30am EST Artelo Biosciences Announces Publication of Positive Non-Clinical Fatty Acid Binding Protein 5 Inhibitor Data in Peer-Reviewed Journal
Oct 29, 2019 8:30am EDT Artelo Biosciences Announces Selection of Aptus Clinical Ltd. as Clinical Research Organization for Phase 1b/2a Study of ART27.13
Oct 22, 2019 9:00am EDT Artelo Biosciences to Present at the Dawson James Securities 5th Annual Small Cap Growth Conference
